Helper Independent Recombinant Adenovirus Vectors: Expression of HIV env or HBV Surface Antigen

References

• Couch R. B., Chanock R. M., Cate T. R., Lang D. J., Knight V., Huebner R. J. Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. Amer. Rev. Resp. Dis 1963; 88: 394
   PubMedGoogle Scholar
• Davis A. R., Kostek B., Mason B., Hsiao C. L., Morin J., Dheer S. K., Hung P. P. Expression of hepatitis B surface antigen with a recombinant adenovirus. Proc. Natl. Acad. Sci. USA 1985; 82: 7560
   PubMed Web of Science ®Google Scholar
• Morin J. E., Lubeck M. D., Barton J. E., Conley A. J., Davis A. R., Hung P. P. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc. Natl. Acad. Sci. USA 1987; 84: 4626
   PubMed Web of Science ®Google Scholar
• Molnar-Kimber K. L., Jarocki-Witek V., Dheer S. K., Vernon S. K., Conley A. J., Davis A. R., Hung R. R. Distinctive properties of the hepatitis B virus envelope proteins. J. Virol 1988; 62: 407
   Google Scholar
• Solnick D. Construction of an adenovirus-SV40 recombinant producing SV40 T antigen from an adenovirus late promoter. Cell 1981; 24: 135
   PubMed Web of Science ®Google Scholar
• Thummel C., Tjian R., Grodzicker T. Expression of SV40 T antigen under control of adenovirus promoter. Cell 1981; 23: 825
   PubMed Web of Science ®Google Scholar
• Graham E. L., Smiley J., Russel W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol 1977; 36: 59
   PubMed Web of Science ®Google Scholar
• Bailey A., Levrero M., Buendia M. A., Tiollais P., Perricaudet M. In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses. EMBO J 1985; 4: 3861
   Google Scholar
• Burgert H. G., Kvist G. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigen. Cell 1985; 41: 987
   PubMed Web of Science ®Google Scholar
• Seversinsson L., Paterson P. A. Abrogation of cell surface expression of human class I transplantation antigens by an adenovirus protein in Xenapus laevis oocytes. J. Cell. Biol 1985; 101: 540
   Google Scholar
• Gooding L. R., Elmore L. W., Tollefson A. E., Brady H. A., Wold W. S. M. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 1988; 53: 341
   PubMed Web of Science ®Google Scholar
• Berkner K. L., Sharp P. A. Generation of adenovirus by transfection of plasmids. Nucleic Acids Res 1983; 11: 6003
   PubMed Web of Science ®Google Scholar
• Kapoor Q. S., Wold W. S. M., Chinnaduri G. A non-essential glycoprotein is coded by early region E3 of adenovirus type 7. Virology 1981; 112: 780
   Google Scholar
• Lubeck M. D., Davis A. R., Chengalvala M., Natuk R. J., Morin J. E., Molnar-Kimber K., Mason B. B., Bhat B. M., Mizutani S., Hung R P., Purcell R. H. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc. Natl. Acad. Sci. USA 1989; 86: 6763
   PubMed Web of Science ®Google Scholar
• Saito I., Oya Y., Yamamoto K., Yuasa T., Shimojo H. Construction of anon-defective adenovirus type 5 bearing a 2.8 kilobase hepatitis B virus DNA near the right end of its genome. J. Virol 1985; 54: 711
   PubMed Web of Science ®Google Scholar
• Yamada M., Lewis J. A., Grodzicker T. Overproduction of the protein product of a non-selected foreign gene carried by an adenovirus vector. Proc. Natl. Acad. Sci. USA 1985; 82: 3567
   PubMed Web of Science ®Google Scholar
• Bernker K. L., Sharp P. A. Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant. Nucleic Acids Res 1984; 13: 841
   Google Scholar
• Mansour S. L., Grodzicker T., Tjian R. Downstream sequences affect transcription initiation from the adenovirus major late promoter. Mol. Cell. Biol 1986; 6: 2684
   PubMedGoogle Scholar
• Hanahan D., Gluzman Y. Rescue of functional replication origins from embedded configuration in a plasmid carrying the adenovirus genome. Mol. Cell. Biol 1984; 4: 302
   PubMedGoogle Scholar
• Wain-Hobson S., Sonigo P., Danes O., Cole S., Alizon M. Nucleotide sequence of the AIDS virus,. LAV Cell 1985; 40: 9
   PubMed Web of Science ®Google Scholar
• Knight D. M., Flomerfelt F. A., Gihrayeb J. Expressionof the art/trs protein of HIV and study of its role in viral envelope synthesis. Science 1987; 236: 837
   PubMedGoogle Scholar
• Hadzopoulou-Cladaras M., Felber B. K., Cladaras C., Athanassopoulos A., Tse A., Pavlakis G. N. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol 1989; 63: 1265
   PubMed Web of Science ®Google Scholar
• Hammarskjold M. -L., Heimer J., Hammarskjold B., Sangwan I., Albert L., Rekosh D. Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol 1989; 63: 1959
   PubMedGoogle Scholar
• Goh W. C., Sodroski J. G., Rosen C. A., Haseltine W. A. Expression of the art gene protein of human T-lymphotropic virus type III (HTLV-III) in bacteria. J. Virol 1987; 61: 633
   Google Scholar
• Chanda P. K., Ghrayeb J., Wong-Staal E. Nonrandom distribution of antibodies to the TRS protein of human immunodeficiency virus in infected people with different clinical status. AIDS Res. Hum. Retroviruses 1988; 4: 11
   Google Scholar
• Cullen B. R., Hauber J., Campbell K., Sodroski J. G., Haseltine W. A., Rosen C. A. Subcellular localization of the human immunodeficiency virus trans-acting art gene product. J. Virol 1988; 62: 2498
   PubMedGoogle Scholar
• Malim M. H., Hauber J., Le S. Y., Mizel J. V., Cullen B. R. The HIV-1 rev transactivator acts through a structural target sequence to activate nuclear export of unspliced viral mRNA. Nature 1989; 338: 354
   Google Scholar
• Grantham R., Gautier C., Gouy M., Jacobzone M., Mercier R. Codon usage is a genome strategy modulated for gene expressivity. Nucleic Acids. Res 1981; 9: 43
   PubMed Web of Science ®Google Scholar
• Lifson J. D., Feinberg M. B., Reyes G. R., Rabin L., Banapour B., Chakrabarti S., Moss B., Wong-Staal E., Steimer K. S., Engleman E. G. Induction of CD4 dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature 1986; 323: 725
   PubMed Web of Science ®Google Scholar
• Lifson J. D., Reyes G. R., McGrath M. S., Stein B. S., Engleman E. G. AIDS retrovirus induced cytopathocity; giant cell formation and involvement of CD4 antigen. Science 1986; 232: 1123
   PubMed Web of Science ®Google Scholar
• Sodroski J., Goh W. C., Rosen C., Campbell K., Haseltine W. A. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (London) 1986; 322: 470
   PubMed Web of Science ®Google Scholar
• Lieber M., Smith B., Szakal A., Nelson-Rees W., Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer 1976; 17: 62
   PubMed Web of Science ®Google Scholar
• Top F. H., Jr., Grossman R. A., Bartelloni P. I., Segal H. E., Dudding B. A., Russell P. K., Buescher E. L. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J. Inf. Dis 1971; 124: 148
   PubMed Web of Science ®Google Scholar
• Rice N. R., Copeland T. D., Simeck S., Oroszlan S., Gilden R. V. Detection and characterization of the protein encoded by the v-rel oncogene. Virology 1986; 149: 217
   PubMedGoogle Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970; 227: 680
   PubMed Web of Science ®Google Scholar